US stocks advanced midday Monday, with the S&P 500 and Nasdaq Composite notching fresh all-time intraday highs, buoyed by ...

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

Why didn’t federal prosecutors charge Sean Combs with more obvious, easy-to-prove offenses? Because they can’t help themselves?

The Milwaukee Bucks got everyone's attention with their outside-the-box maneuvers July 1, but national writers aren't sure they'll work.

Ukraine received mixed results during the 2025 NATO summit. Given this ambiguity, time will tell how the NATO-Ukraine relationship will unfold.

Review quarterly and annual revenue, net income, and cash flow for Sarepta Therapeutics Inc (SRPT:XMEX) stock through the last fiscal year.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2025 that were previously approved by the Compensation ...

Recent discussions on X about AST SpaceMobile (ASTS) have been buzzing with activity, largely driven by the company's latest financial maneuvers and analyst coverage. Many users have pointed out ...

Donald Trump and Pete Hegseth go after reporters for coverage of U.S. bombing Iran, especially CNN's Natasha Bertrand and Fox News' Jennifer Griffin.

H.C. Wainwright reiterated a ‘Sell’ rating on Sarepta on Wednesday with a $10 price target. The firm views the FDA as a potential headwind for Sarepta now. Shares of Sarepta traded over 7% lower on ...

Understanding Analyst Ratings: A Comprehensive Breakdown An in-depth analysis of recent analyst actions unveils how financial experts perceive Sarepta Therapeutics.